Newsletter / Paid-only "A hole in the firewall": The WHO Foundation & WHO; "Green shoots" for TRIPS Waiver Talks? By Priti Patnaik / 23 Apr 2021
Newsletter / Paid-only India: The Quagmire for COVAX; Q&A: Hyo Yoon Kang on the financialization of intellectual property & COVID-19 By Priti Patnaik / 20 Apr 2021
Newsletter / Paid-only WHO & WTO converge on bilateral tech transfer for vaccines. What this means for the TRIPS Waiver By Priti Patnaik / 16 Apr 2021
Newsletter / Paid-only WHO’s "Bretton Woods Moment" Dimmed by Member States’ Reluctance To Pay Up More By Priti Patnaik / 9 Apr 2021
Newsletter / Paid-only Pathogens-Sharing & The Pandemic Treaty: The Commercial Link By Priti Patnaik / 2 Apr 2021
Newsletter / Members-only Examining the motivations for a pandemic treaty By Priti Patnaik / 31 Mar 2021
Newsletter / Paid-only Views from a vaccine manufacturer: Q&A - Abdul Muktadir, Incepta Pharmaceuticals; Pandemic Treaty Action By Priti Patnaik / 30 Mar 2021
Newsletter / Paid-only Examining the motivations for a pandemic treaty By Priti Patnaik / 26 Mar 2021
Newsletter / Paid-only Rich countries' stance on local production of vaccines: Smoke and mirrors By Priti Patnaik / 23 Mar 2021
Newsletter / Paid-only WHO donors seek a new tech transfer hub under ACT-A, C-TAP sidelined By Priti Patnaik / 19 Mar 2021
